case_images: PMC4808524_01
case_images: Contrast-enhanced computed tomography at the level of pancreas. Arrow demarcates multiple peripancreatic soft tissue masses to left of the uncinate process.
case_images: CRIONM2016-9751736.001.jpg
case_images: PMC4808524_01_CRIONM2016-9751736.001.jpg
case_images: fig1
case_images: Subsequently, abdominal computed tomography (CT) demonstrated multiple, well-defined, peripancreatic, soft tissue masses to left of the uncinate process (Figure 1), posterior to the pancreatic tail, and near the hepatic hilum (Figure 2).
case_images: Contrast-enhanced computed tomography at the level of pancreas. Arrow demonstrates multiple peripancreatic soft tissue masses posterior to the pancreatic tail.
case_images: CRIONM2016-9751736.002.jpg
case_images: PMC4808524_01_CRIONM2016-9751736.002.jpg
case_images: fig2
case_images: Subsequently, abdominal computed tomography (CT) demonstrated multiple, well-defined, peripancreatic, soft tissue masses to left of the uncinate process (Figure 1), posterior to the pancreatic tail, and near the hepatic hilum (Figure 2).
case_images: Contrast-enhanced computed tomography at the level of pancreas after 3 months of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) treatment demonstrating near complete resolution of previously seen soft tissue masses.
case_images: CRIONM2016-9751736.003.jpg
case_images: PMC4808524_01_CRIONM2016-9751736.003.jpg
case_images: fig3
case_images: Contrast-enhanced CT at the level of pancreas 3 months after initiation of CHOP treatment demonstrated near complete resolution of previously seen soft tissue masses (Figure 3).